Brazilian legislative proposal mandates coverage for atypical Hemolytic-Uremic Syndrome

A new bill in Brazil seeks to mandate the provision of medication for atypical Hemolytic-Uremic Syndrome (aHUS) within the public health system (SUS) and private insurance plans. The legislation remains in the early stages of the parliamentary process, requiring approval from both the Chamber of Deputies and the Senate to become law.